Follow
Rossana Berardi
Rossana Berardi
UniversitÓ Politecnica delle Marche - Ospedali Riuniti di Ancona
Verified email at univpm.it
Title
Cited by
Cited by
Year
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
MC Garassino, JG Whisenant, LC Huang, A Trama, V Torri, F Agustoni, ...
The Lancet Oncology 21 (7), 914-922, 2020
4892020
Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastases
A Lipton, GG Steger, J Figueroa, C Alvarado, P Solal-Celigny, JJ Body, ...
Journal of Clinical Oncology 25 (28), 4431-4437, 2007
4312007
Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study)
C Pinto, F Di Fabio, S Siena, S Cascinu, FLR Llimpe, C Ceccarelli, V Mutri, ...
Annals of Oncology 18 (3), 510-517, 2007
4072007
PD-1 blockade therapy in renal cell carcinoma: current studies and future promises
F Massari, M Santoni, C Ciccarese, D Santini, S Alfieri, G Martignoni, ...
Cancer treatment reviews 41 (2), 114-121, 2015
3822015
Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab
M Scartozzi, E Galizia, S Chiorrini, R Giampieri, R Berardi, C Pierantoni, ...
Annals of oncology 20 (2), 227-230, 2009
3752009
Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment withá…
M Scartozzi, I Bearzi, R Berardi, A Mandolesi, G Fabris, S Cascinu
Journal of clinical oncology 22 (23), 4772-4778, 2004
3232004
Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment withá…
M Scartozzi, I Bearzi, R Berardi, A Mandolesi, G Fabris, S Cascinu
Journal of clinical oncology 22 (23), 4772-4778, 2004
3232004
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable
A Cortellini, M Bersanelli, S Buti, K Cannita, D Santini, F Perrone, R Giusti, ...
Journal for immunotherapy of cancer 7 (1), 1-11, 2019
2082019
Extended efficacy and safety of denosumab in breast cancer patients with bone metastases not receiving prior bisphosphonate therapy
A Lipton, GG Steger, J Figueroa, C Alvarado, P Solal-Celigny, JJ Body, ...
Clinical Cancer Research 14 (20), 6690-6696, 2008
1812008
Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trial
S Cascinu, R Berardi, R Labianca, S Siena, A Falcone, E Aitini, S Barni, ...
The lancet oncology 9 (1), 39-44, 2008
1652008
Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patients
M MandalÓ, M Reni, S Cascinu, S Barni, I Floriani, S Cereda, R Berardi, ...
Annals of oncology 18 (10), 1660-1665, 2007
1542007
Nuclear factor-kB tumor expression predicts response and survival in irinotecan-refractory metastatic colorectal cancer treated with cetuximab-irinotecan therapy
M Scartozzi, I Bearzi, C Pierantoni, A Mandolesi, F Loupakis, A Zaniboni, ...
Journal of Clinical Oncology 25 (25), 3930-3935, 2007
1502007
Metabolic phenotype of bladder cancer
F Massari, C Ciccarese, M Santoni, R Iacovelli, R Mazzucchelli, F Piva, ...
Cancer treatment reviews 45, 46-57, 2016
1392016
Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study
D Santini, M Tampellini, B Vincenzi, T Ibrahim, C Ortega, V Virzi, ...
Annals of oncology 23 (8), 2072-2077, 2012
1302012
Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma
M Santoni, F Massari, C Amantini, M Nabissi, F Maines, L Burattini, ...
Cancer immunology, immunotherapy 62 (12), 1757-1768, 2013
1222013
Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib
C Lolli, U Basso, L Derosa, E Scarpi, T Sava, M Santoni, SJ Crabb, ...
Oncotarget 7 (34), 54564, 2016
1212016
Economic sustainability of anti-PD-1 agents nivolumab and pembrolizumab in cancer patients: recent insights and future challenges
F Tartari, M Santoni, L Burattini, P Mazzanti, A Onofri, R Berardi
Cancer treatment reviews 48, 20-24, 2016
1202016
Molecular biology of sporadic gastric cancer: prognostic indicators and novel therapeutic approaches
M Scartozzi, E Galizia, F Freddari, R Berardi, R Cellerino, S Cascinu
Cancer treatment reviews 30 (5), 451-459, 2004
1122004
Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients
M Pistelli, M De Lisa, Z Ballatore, M Caramanti, A Pagliacci, N Battelli, ...
BMC cancer 15 (1), 1-9, 2015
1112015
Role of maspin in cancer
R Berardi, F Morgese, A Onofri, P Mazzanti, M Pistelli, Z Ballatore, ...
Clinical and translational medicine 2 (1), 1-19, 2013
1092013
The system can't perform the operation now. Try again later.
Articles 1–20